Trazodone

Generic Name
Trazodone
Brand Names
Desyrel, Oleptro
Drug Type
Small Molecule
Chemical Formula
C19H22ClN5O
CAS Number
19794-93-5
Unique Ingredient Identifier
YBK48BXK30
Background

Trazodone is triazolopyridine derivative from the serotonin receptor antagonists and reuptake inhibitors (SARIs) class of antidepressants. It is used in adults and has been shown to be comparable in efficacy to other drugs such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine receptor inhibito...

Indication

Trazodone is indicated for the treatment of major depressive disorder (MDD). It has been used off-label for adjunct therapy in alcohol dependence, and off-label to treat anxiety and insomnia. It may also be used off-label to treat symptoms of dementia, Alzheimer’s disease, schizophrenia, eating disorders, and fibromyalgia due to its effects on various neurot...

Associated Conditions
Alcohol Dependency, Alzheimer's Disease (AD), Anxiety, Dementia, Eating Disorders Symptoms, Fibromyalgia, Insomnia, Major Depressive Disorder (MDD), Pain, Inflammatory, Schizophrenia, Moderate to severe pain
Associated Therapies
-

Quetiapine Versus Trazadone in Women With Postpartum Depression

Early Phase 1
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
50
Registration Number
NCT06546358
Locations
🇨🇦

Parkwood Institute, London, Ontario, Canada

Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia

First Posted Date
2024-02-28
Last Posted Date
2024-06-10
Lead Sponsor
Milton S. Hershey Medical Center
Target Recruit Count
600
Registration Number
NCT06281756
Locations
🇺🇸

National Jewish Health, Denver, Colorado, United States

🇺🇸

Penn State University, Hershey, Pennsylvania, United States

🇺🇸

University of Pittsburgh, Pittsburgh, Pennsylvania, United States

and more 1 locations

Trazodone vs. Quetiapine for the Treatment of ICU Delirium

First Posted Date
2022-04-01
Last Posted Date
2024-05-08
Lead Sponsor
University of Southern California
Target Recruit Count
60
Registration Number
NCT05307003
Locations
🇺🇸

Keck Hospital of the University of Southern California, Los Angeles, California, United States

Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone

First Posted Date
2022-03-29
Last Posted Date
2022-08-11
Lead Sponsor
Verinder Sharma
Target Recruit Count
28
Registration Number
NCT05299398
Locations
🇨🇦

Parkwood Institute Mental Health Care Building, London, Ontario, Canada

Rescue Pharmacotherapy for OSA

First Posted Date
2022-03-24
Last Posted Date
2024-06-04
Lead Sponsor
Brigham and Women's Hospital
Target Recruit Count
70
Registration Number
NCT05293600
Locations
🇺🇸

Sleep Disorders Research Program Brigham and Women's Hospital, Boston, Massachusetts, United States

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

First Posted Date
2022-03-16
Last Posted Date
2024-01-12
Lead Sponsor
Johns Hopkins University
Target Recruit Count
100
Registration Number
NCT05282550
Locations
🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Evaluation of Trazodone in OSA-MCI

Phase 4
Active, not recruiting
Conditions
Interventions
First Posted Date
2022-01-26
Last Posted Date
2024-08-21
Lead Sponsor
Chinese University of Hong Kong
Target Recruit Count
134
Registration Number
NCT05209035
Locations
🇭🇰

The Chinese University of Hong Kong, Hong Kong, Hong Kong

Investigating the Effectiveness of E-CBTi Compared to Pharmaceutical Interventions in Treating Insomnia

Not Applicable
Recruiting
Conditions
Interventions
First Posted Date
2021-11-18
Last Posted Date
2024-10-18
Lead Sponsor
Dr. Nazanin Alavi
Target Recruit Count
60
Registration Number
NCT05125146
Locations
🇨🇦

Queen's University, Kingston, Ontario, Canada

RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ)

First Posted Date
2021-10-20
Last Posted Date
2024-05-08
Lead Sponsor
University of Southern California
Target Recruit Count
30
Registration Number
NCT05085808
Locations
🇺🇸

Keck Hospital of the University of Southern California, Los Angeles, California, United States

CBT-I or Zolpidem/Trazodone for Insomnia

First Posted Date
2020-07-13
Last Posted Date
2024-07-19
Lead Sponsor
California Pacific Medical Center Research Institute
Target Recruit Count
155
Registration Number
NCT04468776
Locations
🇺🇸

University of Missouri, Columbia, Missouri, United States

🇺🇸

Penn State Hershey Medical Center, Hershey, Pennsylvania, United States

🇺🇸

University of Virginia, Charlottesville, Virginia, United States

and more 4 locations
© Copyright 2024. All Rights Reserved by MedPath